Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
0.4786
-0.0343 (-6.69%)
Mar 31, 2025, 2:30 PM EDT - Market open
Century Therapeutics Employees
As of December 31, 2024, Century Therapeutics had 150 total employees, including 140 full-time and 10 part-time employees. The number of employees decreased by 15 or -9.09% compared to the previous year.
Employees
150
Change (1Y)
-15
Growth (1Y)
-9.09%
Revenue / Employee
$43,927
Profits / Employee
-$843,773
Market Cap
41.18M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 150 | -15 | -9.09% |
Dec 31, 2023 | 165 | -19 | -10.33% |
Dec 31, 2022 | 184 | -4 | -2.13% |
Dec 31, 2021 | 188 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IPSC News
- 11 days ago - Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 5 months ago - Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 5 months ago - Century Therapeutics to Present at Guggenheim's Inaugural Healthcare Innovation Conference - GlobeNewsWire
- 6 months ago - Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer - GlobeNewsWire
- 8 months ago - Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 10 months ago - Century Therapeutics: Cell Therapy Biotech With Expanded Potential Of CNTY-101 - Seeking Alpha
- 10 months ago - Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting - GlobeNewsWire